李强主持召开国务院常务会议 部署复制推广跨境贸易便利化专项行动政策措施

Group 1: National Water Network Construction - The national water network construction is a strategic measure to optimize water resource allocation, enhance flood prevention and disaster reduction capabilities, and ensure national water security [1] - The construction of the national water network is also expected to have multiple effects, including transportation, ecological protection, and tourism, serving as an important vehicle for expanding domestic demand [1] - The investment scale for water network projects is large, involving multiple departments, and requires close coordination and collaboration to ensure smooth implementation [1] Group 2: Cross-Border Trade Facilitation - Cross-border trade facilitation is a key component in creating a first-class business environment, focusing on efficient logistics and multi-modal transport coordination [2] - The development of green trade and cross-border e-commerce is encouraged, along with optimizing the supervision of special goods and supporting bonded zones in conducting bonded testing [2] - Enhancements in smart regulatory services and the construction of smart customs and ports are prioritized to ensure efficient and effective management of imports and exports [2] Group 3: Water Supply Management - Water supply is recognized as a vital public service that affects households, emphasizing the need for coordinated urban and rural water supply development [2] - There is a focus on ensuring water quality safety and the maintenance of water supply infrastructure, including the modernization of supply networks [2] - Water supply units are urged to strictly adhere to regulations and improve operational standards to enhance service levels [2] Group 4: Drug Management Regulations - Timely revisions of drug management laws are deemed crucial for ensuring public safety in medication and promoting a healthy pharmaceutical industry [3] - The meeting emphasizes the need to improve drug research and registration systems and accelerate the review and approval of breakthrough therapies [3] - A strong regulatory stance is maintained to ensure quality oversight throughout the drug supply chain and to combat illegal activities in the pharmaceutical sector [3]